Akrimax Pharmaceuticals has acquired Wyeth’s drug product manufacturing and packaging plant in Rouses Point, NY. In late 2005, Wyeth announced plans to phase out operations at the Rouses Point plant due to changes in product demand and restructuring of its manufacturing network. The plant is one of the largest private employers in the area, with nearly 800 manufacturing jobs.        Wyeth and Akrimax will cooperate during a transition period that will end in 2009. During this time, Akri...